BSE filing, BSE: 543848. Summary written from the filing by ALFA Finder's alert engine.
Dev Labtech Venture Ltd: key numbers
- Share price
- ₹23.41
- Market cap
- ₹111.1 Cr
- Revenue (annual)
- ₹167.2 Cr
- Net profit (annual)
- ₹9.57 Cr
- P/E (TTM)
- 11.6×Sector 50.0×
- Promoter holding
- 56.69%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dev Labtech Venture Ltd
All →Dev Labtech Venture Board Meeting Date
Dev Labtech Venture schedules a board meeting on 6 November 2026 to approve half-year standalone and consolidated results. The trading window stays closed until 48 hours after results are declared.
Dev Labtech Venture Other Announcement
Dev Labtech Venture Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture will hold an EGM to approve the preferential issue of 1.37 crore convertible warrants, raising ₹17.81 Crore.
- Value
- ₹17.81 Cr
Dev Labtech Venture Capital Structure Change
Dev Labtech Venture Limited announced an increase in authorized share capital from 50 million to 62 million equity shares, each with a face value of Rs 5.
Dev Labtech Venture Fund Raise of ₹17.81 Cr
Dev Labtech Venture approved the preferential issue of 1.37 crore convertible warrants aggregating ₹17.81 crore. The company also increased its authorised share capital for future expansion.
- Value
- ₹17.81 Cr
Dev Labtech Venture Board Meeting Date
Dev Labtech Venture Ltd has scheduled a board meeting for October 7, 2026, to discuss raising funds via preferential allotment and increasing authorized share capital.
Other bonus issue announcements
All →Shivalik Bimetal Controls Bonus Issue
Shivalik Bimetal added a bonus share proposal and interim dividend to its 04 November 2026 board agenda. Trading window remains closed until 06 November 2026.
Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.